Trial Profile
Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Focus on Cost-effective Analysis and Safety Comparison Between Rivaroxaban and Enoxaparin
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 04 Oct 2019
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Enoxaparin sodium
- Indications Deep vein thrombosis; Pulmonary embolism
- Focus Adverse reactions; Therapeutic Use
- 09 Oct 2017 New trial record